Education
About Us
Working with TipRanks
Follow Us
Baxter International Inc (BAX)
:BAX
BAX Stock Chart & Stats
$18.47
$0.05(0.17%)
At close: 4:00 PM EST
$18.47
$0.05(0.17%)
Day’s Range― - ―
52-Week Range$18.42 - $37.74
Previous CloseN/A
Volume899.70K
Average Volume (3M)6.53M
Market Cap
$9.49B
Enterprise ValueN/A
Total Cash (Recent Filing)$1.69B
Total Debt (Recent Filing)$9.72B
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Feb 12, 2026EPS Estimate
0.55Last Dividend Ex-Date
Aug 29, 2025Dividend Yield3.68%
Share Statistics
EPS (TTM)0.69
Shares Outstanding513,621,030
10 Day Avg. Volume8,065,312
30 Day Avg. Volume6,532,237
Financial Highlights & Ratios
PEG Ratio0.18
Price to Book (P/B)2.14
Price to Sales (P/S)1.40
P/FCF Ratio26.60
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$23.67Price Target Upside28.15% Upside
Rating ConsensusHold
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDespite challenges, adjusted EPS of $0.69 surpassed the consensus estimate of $0.60, aided by a lower-than-expected tax rate.
Leadership And StrategyThe dividend cut is seen as a first sign of how aggressive new CEO Andrew Hider will be in improving BAX’s overall financial health via deleveraging and an improving balance sheet.
Operational EfficiencyCEO Andrew Hider introduced a near-term action plan focusing on business stabilization, balance sheet enhancement, and operational efficiency improvement.
Bears Say
Guidance And OutlookBAX lowered FY25 sales growth and EPS guidance, raising concerns about future performance.
Sales PerformanceBAX shares came under pressure delivering a 3Q25 sales miss across all businesses except Advanced Surgery and also cutting its quarterly dividend.
Stock PerformanceA lower price target of $21 reflects a justified lower multiple given the 3Q25 guidance miss and lingering uncertainty into 2026 growth drivers.
Baxter International News
BAX FAQ
What was Baxter International Inc’s price range in the past 12 months?
Baxter International Inc lowest stock price was $18.42 and its highest was $37.74 in the past 12 months.
What is Baxter International Inc’s market cap?
Baxter International Inc’s market cap is $9.49B.
When is Baxter International Inc’s upcoming earnings report date?
Baxter International Inc’s upcoming earnings report date is Feb 12, 2026 which is in 101 days.
How were Baxter International Inc’s earnings last quarter?
Baxter International Inc released its earnings results on Oct 30, 2025. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.598 by $0.092.
Is Baxter International Inc overvalued?
According to Wall Street analysts Baxter International Inc’s price is currently Undervalued.
Does Baxter International Inc pay dividends?
Baxter International Inc pays a Quarterly dividend of $0.17 which represents an annual dividend yield of 3.68%. See more information on Baxter International Inc dividends here
What is Baxter International Inc’s EPS estimate?
Baxter International Inc’s EPS estimate is 0.55.
How many shares outstanding does Baxter International Inc have?
Baxter International Inc has 513,621,030 shares outstanding.
What happened to Baxter International Inc’s price movement after its last earnings report?
Baxter International Inc reported an EPS of $0.69 in its last earnings report, beating expectations of $0.598. Following the earnings report the stock price went down -14.541%.
Which hedge fund is a major shareholder of Baxter International Inc?
Currently, no hedge funds are holding shares in BAX
Baxter International Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Baxter International Inc
Baxter International Inc. is a global healthcare company that specializes in the development, manufacturing, and marketing of a broad range of medical products. The company operates primarily in two segments: Hospital Products and Renal. Baxter's core products include intravenous (IV) solutions, infusion systems, and renal care products like dialysis equipment. The company is dedicated to improving patient outcomes and enhancing the safety and efficiency of healthcare delivery through innovative products and therapies.
BAX Company Deck
BAX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Baxter International's earnings call highlighted revenue growth in key segments, particularly in Advanced Surgery and Healthcare Systems & Technologies. However, significant challenges exist, notably with the Infusion Therapies and Pharmaceuticals segments, as well as the decision to reduce the dividend for deleveraging purposes. The company's focus on stabilizing business operations, improving the balance sheet, and driving continuous improvement reflects a proactive approach to addressing these challenges.View all BAX earnings summariesBAX Net sales Breakdown
48.96% Medical Products and Therapies
27.75% Healthcare Systems and Technologies
22.67% Pharmaceuticals
0.63% Other
BAX Stock 12 Month Forecast
Average Price Target
$23.67
▲(28.15% Upside)
Technical Analysis
Ownership Overview
0.46% Insiders
35.04% Mutual Funds
0.17% Other Institutional Investors
38.89% Public Companies and
Individual Investors